An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems

JOURNAL OF HEART AND LUNG TRANSPLANTATION

卷:37

Article

Lavee, Jacob¹  Mulzer, Johanna²  Krabatsch, Thomas²  Marasco, Silvana³  McGiffin, David³  Garbade, Jens⁴  Schmitto, Jan D.⁵  Zimpfer, Daniel⁶  Potapov, Evgenij V.² 

[1] Tel Aviv Univ, Sheba Med Ctr, Leviev Heart Ctr, Heart Transplantat Unit,Dept Cardiac Surg, Tel Aviv, Israel

[2] German Heart Ctr, Cardiac Thorac & Vasc Surg, Berlin, Germany

[3] Alfred Hosp, Cardiothorac Surg & Transplantat, Melbourne, Vic, Australia

[4] Univ Leipzig, Ctr Heart, Leipzig, Germany

[5] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, Hannover, Germany

[6] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria

关键词: bi-ventricular assist device;    bi-ventricular failure;    continuous flow ventricular assist device;    left ventricular assist device;    right ventricular assist device;    total artificial heart;   

DOI  :  10.1016/j.healun.2018.08.008

来源: Elsevier

【 摘 要 】

Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support. (C) 2018 International Society for Heart and Lung Transplantation. All rights reserved.

【 授权许可】

Free